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In the Level 2 Special Care Baby Unit (SCBU), Nambour
General Hospital, Nambour, Queensland, it is common practice
for cot-side glucose meters to be used to screen for neonatal
hypoglycaemia. They provide a rapid, simple and less expensive
method of estimating blood glucose compared with laboratory
analysis. Glucose meters, however, have been shown to be
imprecise and prone to interference.1–5 Glucose meters are most
inaccurate for glucose levels less than 3.0 mmol/L, which are
the values of most concern to paediatricians.6–8
The management of cot-side glucose meter readings of less
than 2.6 mmol/L is to confirm the result by laboratory analysis.
Furthermore, if the glucose meter recorded a result less than
2.0 mmol/L (with a delay in confirmation of results expected of
up to 60 min) a glucose infusion is commenced. If the labora-
tory analysis shows a satisfactory glucose level, the neonate
has been over-treated, undergone unnecessary invasive proce-
dures and has been exposed to possible infection, pain and
blood loss. In addition, there has been mother/baby separation
during a crucial time of bonding, and a delay in the initiation of
breastfeeding. This invasive treatment could be avoided if there
was a quicker, more accurate method available for assessing
the blood glucose.
The aims of this study were: (i) To evaluate in the clinical
setting two electrochemical glucose meters, the Advantage
Glucose Meter (Roche Diagnostics, Castle Hill, Australia) and
the Precision-G Blood Glucose Testing System (Medisense,
Melbourne, Australia), for precision and accuracy, compared to
the ABL 620 Blood Gas Analyser with an electrochemical
glucose oxidase electrode; and (ii) to determine which method of
first-line blood glucose determination (Advantage glucose meter,
Precision-G glucose meter, and ABL 620 blood gas analyser
with an electrochemical glucose oxidase electrode; Radiometer,
Copenhagen, Denmark) was most acceptable to those carrying
out blood collection and analysis (i.e. the nursing staff).
METHODS
This was a prospective study performed over a 5-month period,
from August 1998 to February 1999, in the Level 2 SCBU of
the Nambour General Hospital, Nambour.
Subjects
Whole blood was obtained from a non-random group of
neonates who had an indication for blood glucose screening
(infants of insulin-dependent diabetic or gestational diabetic
mothers, low birthweight infants, small for gestational age
infants, preterm infants and those with evidence of perinatal
asphyxia). Informed written consent was obtained from the
infant’s parent(s) prior to the procedure.
Equipment
The glucose meters used in the study were the Advantage
Glucose Meter and the Precision-G Blood Glucose Testing
System. These glucose meters use electrochemical bio-sensors
to determine the glucose level, compared with the cotside
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glucose meters traditionally used which are photometers
relying on reflectance-based technology. The electrochemical
detection technique uses an enzymatic reaction (glucose
oxidase for the Precision-G and glucose dehydrogenase for the
Advantage) to generate a current which is measured by the
meter. The size of the current is proportional to the amount of
glucose present in the drop of blood, which gives an accurate
reading. The older reflectance meters used a colorimetric
reaction. The colour generated is dependent on the amount of
glucose present and is interpreted electronically by the
reflectance meter giving a qualified blood glucose value. This
method is dependent on user technique, adequate cleaning of
the photometric window, can be interferred with by skin prepa-
rations, and the size of blood sample. These problems are not
encountered with the new meters, which allow universal
sampling (capillary, arterial and venous blood), and quick
analysis. There is no requirement for wiping, blood can be re-
applied, and the strips can be handled without interference thus
reducing the source of analytical and user error.
The Advantage Glucose Meter was already in use within the
SCBU, and the Precision-G glucose meter was considered as a
viable alternative. Both glucose meters have been specifically
recommended to accurately estimate neonatal blood glucose.
The ABL 620 blood gas analyser (Radiometer, Copenhagen,
Denmark), with attached electrochemical glucose oxidase
electrode, was used as the reference method in determining the
true blood glucose (TBG). It has been shown to be very precise
and to provide reliable and accurate results.9 A recent study
demonstrated the ABL 620 to have a high correlation with the
reference laboratory method.10 The ABL 620 uses a multilayer
membrane with glucose oxidase immobilized between the
inner and outer membrane. The outer membrane has pores of
well-defined density limiting the crossing of red cells into the
glucose oxidase layer. The enzymatic reaction generates a
current, which the Analyser converts to a plasma glucose
concentration.
All three methods use whole blood for analysis of blood
glucose. Whole blood glucose concentration is influenced by
haematocrit (HCT), with high HCT giving a lower apparent
blood glucose concentration. The manufacturers claim that the
Advantage Glucose Meter is not affected by a HCT of 0.2–0.65,
and the Precision-G a HCT of 0.2–0.7. The ABL 620 showed no
interference by HCT for a range of 0.35–0.75 IU/L10 and this was
due to the outer low-porous membrane. A haematocrit level was
measured by the ABL 620 (on the same sample of blood), to test
for possible interference with the glucose result.11
Procedure
Thirteen selected members of the neonatal nursing staff
received in-service training on the study protocol, correct blood
collection technique and machine procedure prior to the com-
mencement of the study. Daily quality control checks were
carried out on the Advantage and Precision-G blood glucose
meters, in accordance with the manufacturer’s guidelines. The
ABL 620 was calibrated by the staff of the Pathology Depart-
ment at the recommended times, in compliance with manufac-
turer’s guidelines.
An arterial or capillary blood specimen was collected on
each occasion. This single specimen was used for each of the
three machines: the two glucose meters and for measurement
of the TBG.
The volume required for the Advantage and Precision-G
glucose meters, was one large drop, or 0.02 mL each. The ABL
620 required 0.09 mL if using a capillary tube or 0.3 mL if a
heparinized syringe was used.
Arterial blood was collected from indwelling arterial lines
and capillary samples from heel pricks. Arterial blood was
collected into a 1-mL preheparinised syringe. Single drops
were expelled to completely cover the test windows on the
Advantage and Precision-G strips. The remainder (0.3 mL) was
transferred immediately to the intensive care unit to be
analyzed using the ABL 620 glucose Analyser. The syringe
was inverted several times and air bubbles were removed prior
to insertion of blood into the required port. Haematocrit was
also measured at this time.
Capillary blood was collected from a pre-warmed heel after
the first drop was wiped away. The next two drops were used to
fully cover the windows on the Advantage and Precision-G strips.
A capillary tube collected the next drop and was capped securely.
A magnet was used to slide the mixing wire in the capillary tube.
The blood was then inserted into the ABL 620 Glucose Analyser.
The capillary tube contained no inhibitors of glycolysis and the
specimen was tested within 15 min of collection.
Records were kept of the glucose meter blood glucose levels
for both meters, the TBG, HCT, and any delay in obtaining a
result. The nursing staff were asked to comment on any difficul-
ties encountered with the procedure, including delays and/or
machine difficulty. The nursing staff completed a questionnaire,
rating the ABL 620, Advantage, and Precision-G glucose
meters, on ‘ease of use’. A scale of 1–5 was used with 1 being
very easy and 5 being very difficult.
The Research Ethics Committee of The Royal Women’s
Hospital and District Health Service, Brisbane, gave ethical
approval for the study.
Statistical methods
Comparison of means for continuous non-skewed data were
analysed using the Student’s t-test. Comparison of medians for
continuous skewed data were analyzed using the Kruskal–Wallis
and Mann–Whitney tests. Differences between individual
glucose meter measurements and the TBG were plotted against
the TBG as a percentage of the TBG. The mean percentage
difference between individual glucose meter measurements and
the TBG (as a percentage of the TBG) was calculated. The closer
the mean difference to zero, the greater the accuracy, and the
smaller the standard deviation (SD) around the mean the greater
the precision, as compared with the TBG. Sensitivity, specificity,
likelihood ratios of a positive and negative test, positive predic-
tive value (PPV) and negative predictive value (NPV) were
calculated for both the Advantage and Precision-G machines for
the diagnosis of hypoglycaemia (≤ 2.6 mmol/L). Data were
entered into and analysed with Microsoft Excel 97 (Microsoft
Corporation, Washington, USA) and Minitab for Windows
(version 11; Minitab Inc., State College, USA) software.
RESULTS
A total of 108 samples were collected from 47 neonates. TBG
was measured on 83 occasions. The 25 unavailable results from
the ABL 620 were due to: insufficient sample (11), capillary
sample insufficient and specimen clotted in tube (4), operator
error (2), measurement aborted reason unknown (4), and
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broken capillary tube (2). On two occasions a reason was not
given. Results for the Advantage Glucose Meter were unavail-
able on one occasion and a reason was not reported. Results for
the Precision-G Glucose Meter were unavailable on two
occasions. One was due to insufficient sample and the other
due to machine failure. The Precision-G glucose meter had one
reading recorded at < 1.1 and as this was not an absolute value
it was not included in the data analysis.
Haematocrit was measured on 88 (81%) of the samples
collected. Data was unavailable because of insufficient speci-
mens, including clots and broken capillary tubes (17), operator
error (2) and a malfunction of the ABL 620 on one occasion.
The mean (SD) haematocrit was 0.60 (0.08) I/L with a range
from 0.42 to 0.78 I/L.
There were 82 and 81 blood glucose levels measured by the
Advantage and Precision-G glucose meters, respectively,
paired with a TBG. Comparisons between the Advantage Glu-
cose Meter and TBG are summarized in Table 1. The means of
absolute blood glucose values are not significantly different for
all measurements. The mean (SD) percentage difference
between measurements was 4.5% (12.5), which is close to zero.
Figure 1 shows the percentage difference between measure-
ments plotted against the TBG (r2 = 0.223, P < 0.001). This
shows that the Advantage Glucose Meter under-read more with
higher TBG and this seemed to be more pronounced at TBG 
> 4 mmol/L. The differences between measurements for TBG
≤ 4 mmol/L and > 4 mmol/L (see Table 1) were analysed. The
mean (SD) percentage difference between measurements for
TBG: > 4 mmol/L was 0.6% (13.9). The mean (SID) per-
centage difference between measurements for TBG > 4 mmol/L
was 8.6% (8.8). In the clinically important range of TBG, from
2 to 3 mmol/L, the mean (SD) percentage difference was 
– 4.0% (14.4). Figure 2 shows the percentage difference
between measurements plotted against HCT. The fitted line
plot was almost horizontal with a coefficient of determination
(r2) of 0.02 (P = 0.27); therefore the HCT did not influence
the degree of difference between measurements. The overall
performance of the Advantage Glucose Meter in diagnosing
hypoglycaemia (for all measurement pairs and for measure-
ment pairs over the clinically important range where the TBG
is: ≤ 4.0 mmol/L) is summarized in Table 2. The regression
equation for the prediction of TBG from the Advantage
glucose meter reading is:
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Table 1 Blood glucose measurement (mmol/L) for paired samples between glucose meters and total blood glucose with percentage differences.
Data are mean (SD)
Advantage
TBG Glucose Meter Difference†
mmol/L (%) mmol/L (%) P value* mmol/L (%)
All pairs, n = 82 4.0 (1.10) 3.7 (0.95) 0.14 4.5 (12.5)
TBG ≤ 4, n = 44 3.1 (0.61) 3.1 (0.57) 0.64 0.6 (13.9)
TBG > 4, n = 38 5.0 (0.64) 4.5 (0.67) 0.0032 8.6 (8.8)
Precision-G Difference‡
TBG glucose meter P value* (%)
All pairs, n = 81 4.0 (1.13) 3.4 (1.02) 0.0002 15.4 (12.4)
TBG ≤ 4, n = 43 3.1 (0.62) 2.7 (0.56) 0.0008 13.5 (11.6)
TBG > 4, n = 38 5.0 (0.64) 4.1 (0.86) < 0.0001 17.5 (13.0)
TBG, total blood glucose. *Student’s t-test. †The difference between paired measurements as a percentage of the total blood glucose (TBG), i.e.
(TBG – Advantage)/TBG · 100. ‡The difference between paired measurements as a percentage of the TBG, i.e. (TBG – Precision-G)/TBG · 100.
Fig. 1 Percentage difference between the total blood glucose (TBG)
and the Advantage glucometer readings versus the TBG, with fitted line
plot (bold line) and 95% confidence intervals (faint lines). y = 5.264x –
16.477; r2 = 0.2229.
Fig. 2 Percentage difference between the total blood glucose and the
Advantage glucometer readings versus the haematocrit, with fitted line
plot (bold line) and 95% confidence intervals (faint Iines). y = 0.2178x
+ 18.1; r2 = 0.0161.
TBGmmoI/L = 0.026 + (1.06 · ADVmmoI/L)
r2 = 0.82 P < 0.001 s = 0.486,
allowing the calculation of a predicted TBG with approximate
95% prediction intervals of ± 0.97 mmol/L.
Comparisons between the Precision-G glucose meter and
TBG are summarized in Table 1. There was a greater difference
between the means of absolute blood glucose values for all the
measurements. The mean (SD) percentage difference between
measurements was 15.4% (12.4). Figure 3 shows the percentage
difference between measurements plotted against the TBG
(r2 = 0.04, P = 0.07). Therefore the Precision-G glucose meter
tended to under-read more with higher TBG but this was not
statistically significant. Analysis of the percentage differences
between measurements for TBG ≤ 4 mmol/L and > 4 mmol/L
is shown in Table 1. The mean (SD) percentage difference
between measurements for TBG ≤ 4 mmol/L was 13.5%
(11.6) mmol/L. The mean (SD) difference between measure-
ments for TBG > 4 mmol/L was 17.5% (13.0). In the clinically
important range of TBG from 2 to 3 mmol/L, the mean (SD)
percentage difference was 10.0% (13.7). Figure 4 shows the
difference between measurements plotted against haematocrit.
The fitted line plot is almost horizontal with (r2) of 0.06 (P =
0.03); therefore the HCT only slightly influences the degree of
difference between measurements. The overall performance of
the Precision-G glucose meter in detecting hypoglycaemia (for
all measurement pairs and for measurement pairs over the clini-
cally important range where the TBG is 
≤ 4.0 mmol/L) is shown in Table 2. The regression equation for
the prediction of TBG from the Precision-G glucose meter
reading is:
TBGmmol/L = 0.773 + (0.96 · PREmmoL/L)
r2 = 0.75 P < 0.001 s = 0.567,
allowing the calculation of a predicted TBG with approximate
95% prediction intervals of ± 1.13 mmol/L.
At the completion of the study, the nursing staff were asked
to compare the ABL 620, and the Advantage and Precision-G
glucose meters with regard to their user acceptability. There
was an overall preference for the Advantage Glucose Meter for
it’s ‘ease of use’ and convenience, with 13/13 (100%) nurses
rating it the easiest to use and the most convenient. The ABL
620 was the least preferred for convenience and ‘ease of use’.
Problems encountered by the nursing staff when using the ABL
620 included: difficulty in collecting blood into the capillary
tubes, difficulty with the technical detail required in working
the machine and the inconvenience of the machine’s location.
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Table 2 Test performance characteristics for the Advantage and Precision-G glucose meters for detection of neonatal hypoglycaemia (< 2.6 mmol/L),
for all measurement pairs and for measurement pairs where the TBG is ≤ 4.0 mmol/L
Sensitivity Specificity PPV NPV Positive Negative
(%) (%) (%) (%) LR LR
All pairs
Advantage 89 99 89 99 65 0.11
Precision-G 100 88 50 100 8 0
Pairs TBG: ≤ 4.0
Advantage 89 97 89 97 31 0.11
Precision-G 100 74 50 100 3.8 0
PPV, positive predictive value; NPV, negative predictive value; positive LR, likelihood ratio of a positive test; negative LR, likelihood ratio of a
negative test.
Fig. 3 Percentage difference between the total blood glucose (TBG)
and the Precision-G glucometer readings versus the TBG, with fitted line
plot (bold line) and 95% confidence intervals (faint lines). y = 2.1892x +
6.6659; r2 = 0.0399.
Fig. 4 Percentage difference between the total blood glucose and
Precision-G glucometer readings versus the haematocrit, with fitted
line plot (bold line) and 95% confidence intervals (faint lines).
y = 0.4117x – 9.3451; r2 = 0.0577.
They reported that with the Precision-G glucose meter, entering
patient information was more arduous, and the machine more
cumbersome. The median (lQR) ‘ease of use’ rating for the three
methods were: 1.0 (1.0–1.0) for the Advantage, 2.0 (1.5–3.0) for
the Precision-G, and 3.0 (2.5–5.0) for the ABL 620. These differ-
ences are statistically significant, P < 0.001, Kruskal–Wallis test.
Post-test, Mann–Whitney tests revealed significant differences
between the Advantage and the ABL 620 (P < 0.0001), and the
Advantage and the Precision-G (P = 0.0014).
On nine of 83 (11%) occasions where the TBG was
measured with the ABL 620, the result was delayed by ‡ 5 min.
No such delays were experienced with the Advantage and the
Precision-G glucose meters.
DISCUSSION
Two glucose electrochemical meters were compared for evalu-
ation against a glucose oxidase analyser. Both glucose meters
were specifically recommended by their manufacturers for use
in neonates. The Advantage Glucose Meter was more accurate
and had similar precision compared with the Precision-G
glucose meter with a mean percentage difference closer to zero
and a similar (SD). This mean difference of 4.5% (0.2 mmol/L)
for the Advantage Glucose Meter was also similar to that found
by Perkins et al.12 The accuracy of the Advantage was better
for measuring blood glucose levels less than 4 mmol/L. The
mean difference of 15.4% (0.6 mmol/L) found for the
Precision-G meter would be unacceptable in clinical practice
and this machine was even more unreliable for TBG values
above 4 mmol/L with mean (SD) of 17.5% (13.0).
Hypoglycaemia in neonates is diagnosed as a plasma blood
glucose of less than 2.6 mmol/L. Controversy remains regarding
the definition of hypoglycaemia,7,13–15 but it has become a
safe clinical practice to maintain blood glucose levels above
2.6 mmol/L.8,13,14 The purpose of cot-side glucose meters
should be to determine hypoglycaemia in at-risk neonates,
however, it has been observed that cot-side glucose meters over-
estimate hypoglycaemia6,8,15 and neonates are treated unneces-
sarily for the incorrect diagnosis.1,2,16 Missed hypoglycaemia
occurs less frequently.8,15 The Advantage Glucose Meter was
very specific and had adequate sensitivity, which would result 
in a rare over-diagnosis of hypoglycaemia. The Precision-G
glucose meter was significantly less specific and with a sensi-
tivity of 100% and a positive predictive value of only 50%,
over-diagnosis of hypoglycaemia would occur frequently. The
positive test likelihood ratio is superior for the Advantage
Glucose Meter in the diagnosis of hypoglycaemia. The negative
test likelihood ratios are good for both glucose meters.
The Advantage and Precision-G glucose meters are similar in
that they use electrochemical technology to determine the
glucose result. They differ from older systems, which use
photometric technology. Our results show better sensitivity and
specificity of the electrochemical glucose meters in the
detection of neonatal hypoglycaemia, as compared with other
glucose meters which rely on reflectance based technology.1,2,17
Cot-side glucose meters have been shown to give erroneously
low readings of glucose levels in the context of high haematocrit
value11 and this creates a problem when neonatal haematocrit
samples vary between 0.4 and 0.7 I/L. In this study, no influence
by haematocrit was found for the Advantage Glucose Meter for
the haematocrit range between 0.42 and 0.78 I/L. There was only
a slight effect on the Precision-G by haematocrit.
A secondary objective of our study was to determine which
of the three machines would be acceptable for first-line blood
glucose measurement within our nursery. A key component 
of this is the user acceptability. The ABL 620 is known to 
be an accepted method to determine true blood glucose in
neonates,9,10 however, there were a number of problems
encountered by the nursing staff using this machine. There
were several ‘insufficient specimens’ for the ABL 620. This
may have been because blood was collected firstly for the
glucose meters, and might not occur in the clinical setting if
blood was collected for only one machine. The nursing staff
also found the ABL 620 difficult to use. The Advantage and
Precision-G glucose meters were easy to use with minimal
technical problems, but there was a clear preference for the
Advantage Glucose Meter. This preference for the Advantage
Glucose Meter may be because they were already familiar with
its use. Both the ABL 620 and Precision-G glucose meter were
introduced as new instruments. The ‘ease of use’ comparison is
subject to considerable bias because of this, and thus, should be
interpreted with caution. The ‘ease of use’ comparison would
be more valid if the staff had equal or no prior experience with
each instrument. In choosing a device to determine blood
glucose in neonates, it is important to take into consideration
not only its precision and accuracy but also its user accept-
ability. Nursing staff are the most frequent users of glucose
meters and thus, their input was valuable in the process of eval-
uating a glucose meter.
We conclude that the Advantage Glucose Meter is most
suitable for use as the first-line screening device for neonatal
hypoglycaemia. It is significantly more accurate than the
Precision-G glucose meter with similar precision, and has a
high degree of user acceptability. Measurement of the TBG
with the ABL 620 was, at times, slower and is technically
demanding.
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